Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 200

1.

Omega-3 fatty acids for cardioprotection.

Lee JH, O'Keefe JH, Lavie CJ, Marchioli R, Harris WS.

Mayo Clin Proc. 2008 Mar;83(3):324-32. doi: 10.4065/83.3.324. Review. Erratum in: Mayo Clin Proc. 2008 Jun;83(6):730.

PMID:
18316000
2.

n-3 fatty acids and cardiovascular disease.

Breslow JL.

Am J Clin Nutr. 2006 Jun;83(6 Suppl):1477S-1482S. Review.

3.

U.S. adults are not meeting recommended levels for fish and omega-3 fatty acid intake: results of an analysis using observational data from NHANES 2003-2008.

Papanikolaou Y, Brooks J, Reider C, Fulgoni VL 3rd.

Nutr J. 2014 Apr 2;13:31. doi: 10.1186/1475-2891-13-31. Erratum in: Nutr J. 2014;13:64.

4.

Omega-3 fatty acids and cardiovascular disease: new developments and applications.

Harris WS, Dayspring TD, Moran TJ.

Postgrad Med. 2013 Nov;125(6):100-13. doi: 10.3810/pgm.2013.11.2717. Review.

PMID:
24200766
5.

[Treatment of hypertriglyceridemia with omega-3 fatty acids].

Miyoshi T, Ito H.

Nihon Rinsho. 2013 Sep;71(9):1650-4. Review. Japanese.

PMID:
24205729
6.

Update on marine omega-3 fatty acids: management of dyslipidemia and current omega-3 treatment options.

Weintraub H.

Atherosclerosis. 2013 Oct;230(2):381-9. doi: 10.1016/j.atherosclerosis.2013.07.041. Epub 2013 Jul 31. Review.

7.

Risk stratification by the "EPA+DHA level" and the "EPA/AA ratio" focus on anti-inflammatory and antiarrhythmogenic effects of long-chain omega-3 fatty acids.

Rupp H, Wagner D, Rupp T, Schulte LM, Maisch B.

Herz. 2004 Nov;29(7):673-85. Review. Erratum in: Herz. 2004 Dec;29(8):805.

PMID:
15580322
8.

Omega-3 polyunsaturated fatty acids and cardiovascular diseases.

Lavie CJ, Milani RV, Mehra MR, Ventura HO.

J Am Coll Cardiol. 2009 Aug 11;54(7):585-94. doi: 10.1016/j.jacc.2009.02.084. Review.

9.

n-3 fatty acids and cardiovascular events after myocardial infarction.

Kromhout D, Giltay EJ, Geleijnse JM; Alpha Omega Trial Group.

N Engl J Med. 2010 Nov 18;363(21):2015-26. doi: 10.1056/NEJMoa1003603. Epub 2010 Aug 28.

10.

Role of prescription omega-3 fatty acids in the treatment of hypertriglyceridemia.

McKenney JM, Sica D.

Pharmacotherapy. 2007 May;27(5):715-28. Review.

PMID:
17461707
12.

Omega-3 dietary supplements and the risk of cardiovascular events: a systematic review.

Marik PE, Varon J.

Clin Cardiol. 2009 Jul;32(7):365-72. doi: 10.1002/clc.20604. Review.

13.

Omega-3 fatty acid supplements in women at high risk of breast cancer have dose-dependent effects on breast adipose tissue fatty acid composition.

Yee LD, Lester JL, Cole RM, Richardson JR, Hsu JC, Li Y, Lehman A, Belury MA, Clinton SK.

Am J Clin Nutr. 2010 May;91(5):1185-94. doi: 10.3945/ajcn.2009.29036. Epub 2010 Mar 24.

14.

n-3 fatty acid dietary recommendations and food sources to achieve essentiality and cardiovascular benefits.

Gebauer SK, Psota TL, Harris WS, Kris-Etherton PM.

Am J Clin Nutr. 2006 Jun;83(6 Suppl):1526S-1535S. Review.

17.

Omega-3 fatty acids from fish oils and cardiovascular disease.

Holub DJ, Holub BJ.

Mol Cell Biochem. 2004 Aug;263(1-2):217-25. Review.

PMID:
15524182
18.

(n-3) fatty acids and cardiovascular health: are effects of EPA and DHA shared or complementary?

Mozaffarian D, Wu JH.

J Nutr. 2012 Mar;142(3):614S-625S. doi: 10.3945/jn.111.149633. Epub 2012 Jan 25. Review.

19.

The utility of omega-3 fatty acids in cardiovascular disease.

Saremi A, Arora R.

Am J Ther. 2009 Sep-Oct;16(5):421-36. doi: 10.1097/MJT.0b013e3180a5f0bb. Review.

PMID:
19092647
20.

Fatty acid facts, Part III: Cardiovascular disease, or, a fish diet is not fishy.

Pauwels EK, Kostkiewicz M.

Drug News Perspect. 2008 Dec;21(10):552-61. doi: 10.1358/dnp.2008.21.10.1314058. Review.

PMID:
19221636
Items per page

Supplemental Content

Write to the Help Desk